Efficacy and Safety of Ciclesonide Nasal Spray in Participants With Seasonal Allergic Rhinitis (SAR) in Russia
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the efficacy and safety of Ciclesonide Nasal Spray
200 microgram (mcg) once daily in the treatment of seasonal allergic rhinitis (SAR) in
Russian participants.